| dc.contributor.author | López Ramos, Hugo Enrique | |
| dc.contributor.author | Torres Castellanos, Lynda | |
| dc.contributor.author | Ponce Esparza, Ingridd Tathiana | |
| dc.contributor.author | Jaramillo, A. | |
| dc.contributor.author | Rodríguez, A. | |
| dc.contributor.author | Moreno Bencardino, C. | |
| dc.date.accessioned | 2022-05-31T17:11:27Z | |
| dc.date.accessioned | 2023-05-10T17:27:10Z | |
| dc.date.available | 2022-05-31T17:11:27Z | |
| dc.date.available | 2023-05-10T17:27:10Z | |
| dc.date.created | 2016 | |
| dc.identifier | https://www.goldjournal.net/article/S0090-4295(16)30744-0/fulltext | spa |
| dc.identifier.issn | 0090-4295 | spa |
| dc.identifier.uri | https://hdl.handle.net/20.500.12032/94351 | |
| dc.description.abstract | Objective To evaluate the efficacy and safety of OnabotulinumtoxinA treatment in the management of overactive bladder syndrome. Materials and Methods A systematic review of the literature and meta-analysis was performed including randomized controlled cli | spa |
| dc.format | PDF | spa |
| dc.format.mimetype | application/pdf | spa |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | * |
| dc.subject | Botulinum Toxin A | spa |
| dc.subject | Placebo | spa |
| dc.subject | Acetylcholine Release Inhibitor | spa |
| dc.subject | Botulinum Toxin A | spa |
| dc.subject | Article | spa |
| dc.subject | Drug Efficacy | spa |
| dc.subject | Drug Megadose | spa |
| dc.subject | Drug Safety | spa |
| dc.subject | Embase | spa |
| dc.subject | Human | spa |
| dc.subject | Medline | spa |
| dc.subject | Meta Analysis | spa |
| dc.subject | Multicenter Study (Topic) | spa |
| dc.subject | Outcome Assessment | spa |
| dc.subject | Overactive Bladder | spa |
| dc.subject | Phase 1 Clinical | spa |
| dc.title | Management of overactive bladder with onabotulinumtoxina : systematic review and meta-analysis | |
